Page last updated: 2024-10-24

pyruvate dehydrogenase complex

Definition

Target type: cellularcomponent

A multi-enzyme complex that catalyzes the oxidative decarboxylation of pyruvate to form acetyl-CoA. The complex comprises multiple copies of three enzymes referred to as E1, E2 and E3: pyruvate dehydrogenase (E1, which may be a homodimer or a heterotetramer of two alpha and two beta subunits, depending on species), dihydrolipoamide S-acetyltransferase (E2), and dihydrolipoamide dehydrogenase (E3). Additional proteins may also be present. [PMID:36863425]

The pyruvate dehydrogenase complex (PDC) is a multi-enzyme complex that catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, a key step in cellular respiration. The complex is located in the mitochondrial matrix of eukaryotic cells and is composed of three major enzyme components: pyruvate dehydrogenase (E1), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3).

E1 is a tetrameric enzyme that catalyzes the decarboxylation of pyruvate and the formation of a hydroxyethyl derivative bound to thiamine pyrophosphate (TPP) in the active site. This hydroxyethyl group is then transferred to the lipoyl moiety of E2.

E2 is a dimeric enzyme with multiple copies of lipoyl domains. The lipoyl moiety is a flexible arm that can swing between the active sites of E1, E2, and E3. The lipoyl group is responsible for carrying the acetyl group from E1 to E2 and the reduced lipoyl group from E2 to E3.

E3 is a dimeric enzyme that oxidizes the reduced lipoyl group of E2 using NAD+ as the electron acceptor. The reduced form of E3 is then reoxidized by electron transfer to FAD, which is then reoxidized by NAD+.

The PDC complex is highly regulated by a variety of mechanisms, including phosphorylation, product inhibition, and allosteric regulation. The complex is also tightly controlled by the availability of its substrates, pyruvate, NAD+, and CoA.

In addition to the three major enzyme components, the PDC complex contains several regulatory proteins, including pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase. These proteins regulate the activity of the complex by phosphorylating and dephosphorylating E1, respectively. Phosphorylation of E1 inactivates the enzyme, while dephosphorylation activates it.

The cellular component of the pyruvate dehydrogenase complex is the mitochondrial matrix. This is the space within the inner membrane of mitochondria where the complex is located. The matrix contains a high concentration of enzymes and other molecules involved in cellular respiration, including the citric acid cycle and oxidative phosphorylation.

The mitochondrial matrix provides the appropriate environment for the PDC complex to function optimally. This includes the presence of substrates, such as pyruvate, NAD+, and CoA, as well as the absence of inhibitory molecules. The matrix also provides a suitable pH and temperature for the complex to operate efficiently.

The PDC complex is an essential component of cellular respiration, playing a critical role in the production of ATP. It is tightly regulated and integrated into the cellular metabolism, ensuring that the complex operates effectively to meet the energy needs of the cell.'
"

Proteins (2)

ProteinDefinitionTaxonomy
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialA [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15119]Homo sapiens (human)
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrialA dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P10515]Homo sapiens (human)

Compounds (12)

CompoundDefinitionClassesRoles
dichloroacetic acidmonocarboxylic acid;
organochlorine compound
astringent;
marine metabolite
nandrolonenandrolone : A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17.

Nandrolone: C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.
17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid
human metabolite
abietic acidabietic acid : An abietane diterpenoid that is abieta-7,13-diene substituted by a carboxy group at position 18.abietane diterpenoid;
monocarboxylic acid
plant metabolite
dehydroabietylaminedehydroabietylamine: has antimalarial activity; structure in first sourcediterpenoid
zeneca zd 6169Zeneca ZD 6169: an ATP-sensitive potassium channel opener; structure given in first source
2-oxindole2-oxindole: RN given refers to parent cpd; structure

indolin-2-one : An indolinone carrying an oxo group at position 2.
gamma-lactam;
indolinone
hyperforinhyperforin : A cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. John's Wort, Hypericum perforatum.

hyperforin: a prenylated acylphloroglucinol derivative; antibiotic component of novoimanine; psychoactive agent in St. John's wort; Russian; structure;
sodium dichloroacetateCPC 211: for intravenous use in patients with closed head injuries and stroke patients; no further information available 12/99
monordenmonorden: inhibits HSP90 Heat-Shock Proteins, DNA topoisomerase VI and human Topoisomerase IIcyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols
antifungal agent;
metabolite;
tyrosine kinase inhibitor
norethisterone-3-oxime
azd 7545AZD 7545: an anilide tertiary carbinol; a pyruvate dehydrogenase kinase 2 inhibitor

AZD7545 : A sulfone that is benzene substituted by [4-(dimethylcarbamoyl)phenyl]sulfonyl, chloro and [(2R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl]amino groups at positions 1, 3 and 4, respectively. It is a potent and non-ATP-competitive inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2) with IC50 of 6.4 nM and exhibits glucose-lowering activity. Also inhibits PDHK1 at higher levels (IC50 = 36.8 nM).
benzamides;
monochlorobenzenes;
organofluorine compound;
secondary carboxamide;
sulfone;
tertiary alcohol;
tertiary carboxamide
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor;
hypoglycemic agent
ver-246608VER-246608: inhibits pyruvate dehydrogenase kinase; structure in first source